Patents by Inventor Raymond Iezzi

Raymond Iezzi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240374131
    Abstract: Described herein is a system and method for correcting a visual field of a subject using a predicted visual field that includes visual field defects from facial contours of the subject. In an embodiment. the predicted visual field may be determined using a three-dimensional (3D) reconstruction of the face of the subject which may be generated from a two-dimensional (2D) image of the subject using a convolution neural network. A system and method for optimizing a head turn angle of a subject for determining a visual field of a subject is also described herein. An optimal head turn angle may be determined using the 3D reconstruction of the face of the subject. In some embodiments, after the visual field is maximized with positioning of the head. residual facial contour induced defects can be predicted and a final corrected field can be generated.
    Type: Application
    Filed: August 1, 2022
    Publication date: November 14, 2024
    Inventors: Cheryl L. Khanna, Raymond Iezzi, Jane M. Matsumoto
  • Patent number: 11874249
    Abstract: Embodiments of the invention include a method for manufacturing sensors and circuit structures. The method can include providing a substrate including a layer of polymer capable of producing graphite in response to the application of energy, a first electrode adjacent to a first via location on the layer of polymer, and an insulating layer over at least a portion of the first electrode and the layer of polymer at the first via location; and applying sufficient energy to the layer of polymer at the first via location through the insulating layer to ablate the insulating layer and to form a first via as mass of graphite that extends into electrical contact with the first electrode and is surrounded by the insulating layer in a plane of the insulating layer.
    Type: Grant
    Filed: August 23, 2018
    Date of Patent: January 16, 2024
    Assignee: Mayo Foundation for Medical Education and Research
    Inventor: Raymond Iezzi
  • Publication number: 20230277728
    Abstract: This document provides methods and materials for performing retinal pigment epithelium transplantation. For example, methods and materials for using fibrin supports for retinal pigment epithelium transplantation are provided.
    Type: Application
    Filed: March 29, 2023
    Publication date: September 7, 2023
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Alan D. Marmorstein, Raymond Iezzi, Jarel K. Gandhi, Jose S. Pulido
  • Patent number: 11684569
    Abstract: Dendrimer-based compositions and methods are provided, that are useful for administering pharmaceutical compositions to target cells and tissues for treatment of ocular diseases including macular degeneration, diabetic retinopathy, and retinitis pigmentosa.
    Type: Grant
    Filed: August 21, 2020
    Date of Patent: June 27, 2023
    Assignee: WAYNE STATE UNIVERSITY
    Inventors: Kannan Rangaramanujam, Raymond Iezzi, Bharath Raja Guru, Sujatha Kannan
  • Patent number: 11679180
    Abstract: This document provides methods and materials for performing retinal pigment epithelium transplantation. For example, methods and materials for using fibrin supports for retinal pigment epithelium transplantation are provided.
    Type: Grant
    Filed: November 13, 2017
    Date of Patent: June 20, 2023
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Alan D. Marmorstein, Raymond Iezzi, Jarel K. Gandhi, Jose S. Pulido
  • Publication number: 20200393406
    Abstract: Embodiments of the invention include a method for manufacturing sensors and circuit structures. The method can include providing a substrate including a layer of polymer capable of producing graphite in response to the application of energy, a first electrode adjacent to a first via location on the layer of polymer, and an insulating layer over at least a portion of the first electrode and the layer of polymer at the first via location; and applying sufficient energy to the layer of polymer at the first via location through the insulating layer to ablate the insulating layer and to form a first via as mass of graphite that extends into electrical contact with the first electrode and is surrounded by the insulating layer in a plane of the insulating layer.
    Type: Application
    Filed: August 23, 2018
    Publication date: December 17, 2020
    Inventor: Raymond Iezzi
  • Publication number: 20200390694
    Abstract: Dendrimer-based compositions and methods are provided, that are useful for administering pharmaceutical compositions to target cells and tissues for treatment of ocular diseases including macular degeneration, diabetic retinopathy, and retinitis pigmentosa.
    Type: Application
    Filed: August 21, 2020
    Publication date: December 17, 2020
    Inventors: Kannan Rangaramanujam, Raymond Iezzi, Bharath Raja Guru, Sujatha Kannan
  • Publication number: 20200061246
    Abstract: This document provides methods and materials for performing retinal pigment epithelium transplantation. For example, methods and materials for using fibrin supports for retinal pigment epithelium transplantation are provided.
    Type: Application
    Filed: November 13, 2017
    Publication date: February 27, 2020
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Alan D. Marmorstein, Raymond Iezzi, Jarel K. Gandhi, Jose S. Pulido
  • Patent number: 10463609
    Abstract: Dendrimer-based compositions and methods are provided, that are useful for administering pharmaceutical compositions to target cells and tissues for treatment of ocular diseases including macular degeneration, diabetic retinopathy, and retinitis pigmentosa.
    Type: Grant
    Filed: October 6, 2008
    Date of Patent: November 5, 2019
    Assignee: WAYNE STATE UNIVERSITY
    Inventors: Kannan Rangaramanujam, Raymond Iezzi, Bharath Rajaguru, Sujatha Kannan
  • Publication number: 20170216200
    Abstract: Dendrimer-based compositions and methods are provided, that are useful for administering pharmaceutical compositions to target cells and tissues for treatment of ocular diseases including macular degeneration, diabetic retinopathy, and retinitis pigmentosa.
    Type: Application
    Filed: February 23, 2017
    Publication date: August 3, 2017
    Inventors: Kannan Rangaramanujam, Raymond Iezzi, Bharath Rajaguru, Sujatha Kannan
  • Publication number: 20170056469
    Abstract: Methods are described for individualizing a patient's treatment for an eye disease that is mediated by vascular-derived endothelial growth factor.
    Type: Application
    Filed: May 1, 2015
    Publication date: March 2, 2017
    Applicant: Mayo Foundation for Medical Education and Research
    Inventor: Raymond Iezzi
  • Publication number: 20160279054
    Abstract: Dendrimer-based compositions and methods are provided, that are useful for administering pharmaceutical compositions to target cells and tissues for treatment of ocular diseases including macular degeneration, diabetic retinopathy, and retinitis pigmentosa.
    Type: Application
    Filed: June 3, 2016
    Publication date: September 29, 2016
    Applicant: Wayne State University
    Inventors: Kannan Rangaramanujam, Bharath Raja Guru, Sujatha Kannan, Raymond Iezzi
  • Publication number: 20110034422
    Abstract: Dendrimer-based compositions and methods are provided, that are useful for administering pharmaceutical compositions to target cells and tissues for treatment of ocular diseases including macular degeneration, diabetic retinopathy, and retinitis pigmentosa.
    Type: Application
    Filed: October 6, 2008
    Publication date: February 10, 2011
    Applicant: WAYNE STATE UNIVERSITY
    Inventors: Rangaramanujam Kannan, Raymond Iezzi, Bharath Rajaguru, Sujatha Kannan
  • Patent number: 6853075
    Abstract: A self-assembled nanobump array structure including a semi-absorbing outer layer provided on at least one nanobump-forming substrate layer, the semi-absorbing outer layer configured to ablate slowly to allow an applied laser energy to be transmitted to the at least one nanobump-forming substrate layer, in which the self-assembled nanobump array structure is formed by an energy and a pressure buildup occurring in the at least one nanobump-forming substrate layer.
    Type: Grant
    Filed: January 28, 2003
    Date of Patent: February 8, 2005
    Assignee: Wayne State University
    Inventors: Gregory W. Auner, Ratna Naik, Simon Ng, Gary W. Abrams, James Patrick McCallister, Raymond Iezzi
  • Publication number: 20040145053
    Abstract: A self-assembled nanobump array structure including a semi-absorbing outer layer provided on at least one nanobump-forming substrate layer, the semi-absorbing outer layer configured to ablate slowly to allow an applied laser energy to be transmitted to the at least one nanobump-forming substrate layer, in which the self-assembled nanobump array structure is formed by an energy and a pressure buildup occurring in the at least one nanobump-forming substrate layer.
    Type: Application
    Filed: January 28, 2003
    Publication date: July 29, 2004
    Inventors: Gregory W. Auner, Ratna Naik, Simon Ng, Gary W. Abrams, James Patrick McCallister, Raymond Iezzi
  • Patent number: 6668190
    Abstract: A drug delivery system includes a plurality of sites, a fluid channel for delivering a drug to one of the plurality sites, and a light channel for delivering light to an area near one of the plurality of sites. The fluid channel is a micro fluidic channel and the light channel is a wave guide. The light channel may also be a fiber optic cable. The light channel directs light at the fluid channel wherein light from the light channel does not substantially exit to the major surface. The drug delivery system selectively delivers drugs to various types of neurologic cells. In operation a solution of a photoactivatable neuro-active drug is delivered to a preselected area in vivo and photoactivated in the solution at the preselected area to stimulate neurological tissue. The neuro-active drug could be an antagonist or agonist of neuronal activity.
    Type: Grant
    Filed: June 14, 2001
    Date of Patent: December 23, 2003
    Assignee: Wayne State University
    Inventors: Raymond Iezzi, Greg Auner, Patrick McAllister, Gary W. Abrams
  • Publication number: 20020042638
    Abstract: A drug delivery system includes a plurality of sites, a fluid channel for delivering a drug to one of the plurality sites, and a light channel for delivering light to an area near one of the plurality of sites. The fluid channel is a micro fluidic channel and the light channel is a wave guide. The light channel may also be a fiber optic cable. The light channel directs light at the fluid channel wherein light from the light channel does not substantially exit to the major surface. The drug delivery system selectively delivers drugs to various types of neurologic cells. In operation a solution of a photoactivatable neuro-active drug is delivered to a preselected area in vivo and photoactivated in the solution at the preselected area to stimulate neurological tissue. The neuro-active drug could be an antagonist or agonist of neuronal activity.
    Type: Application
    Filed: June 14, 2001
    Publication date: April 11, 2002
    Inventors: Raymond Iezzi, Greg Auner, Patrick McAllister, Gary W. Abrams
  • Patent number: 5551432
    Abstract: An ultrasonic probe which performs a two-dimensional scan is supported by a mount having a thread which is driven back and forth by a screw along a third axis. When a two-dimensional scan is completed in a first plane, a motor drives the mount along a guide to a second plane for the next scan. The separation between the planes being the same as the resolution in scanning within a plane. A housing having a slot with sidewalls is employed to guide the mount in traveling to successive plane locations along its axis. Means for orienting the housing in angular position and a support assembly provide moveable support to the orienting means so that minimal force is required to position the probe relative to the patient. An "auto-scroll" feature permits the operator to interactively pan through multiple, adjacent two-dimensional planes at programmable speeds and displacements along a third axis.
    Type: Grant
    Filed: June 19, 1995
    Date of Patent: September 3, 1996
    Assignee: New York Eye & Ear Infirmary
    Inventor: Raymond Iezzi